A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease.
about
Inflammatory bowel disease surgery in the biologic eraAssociation of STAT4 gene rs7574865G > T polymorphism with ulcerative colitis risk: evidence from 1532 cases and 3786 controlsOptimization of the treatment with immunosuppressants and biologics in inflammatory bowel diseaseInflammatory bowel disease: an expanding global health problemAssociation of a common genetic variant in prostate stem cell antigen with cancer risk.Novel surgery for refractory mixed constipation: Jinling procedure - technical notes and early outcomeTumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysisIs faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study.Current opinion on treatment of inflammatory bowel disease in pregnant women.Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.New biologic therapeutics for ulcerative colitis and Crohn's disease.Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis.On the benefit of galls of Quercus brantii Lindl. in murine colitis: the role of free gallic acid.Is Certolizumab Pegol Safe and Effective in the Treatment of Patients with Moderate to Severe Crohn's Disease? A Meta-analysis of Controlled Clinical Trials.Infliximab administration prior to surgery does not increase surgical site infections in patients with ulcerative colitis.
P2860
Q26745627-6E019BA8-3E1E-4033-AF17-77CB127E8F23Q26862991-44210327-CAFA-4C7F-B2EA-C7F9AD97E9B1Q26866940-3036FE88-481B-44D7-A680-E3D9304DDC2EQ33608406-F0A3AE3D-689C-4B19-89FB-E26110D9749CQ33935316-BAF9CCCD-B5CE-4B99-B1E7-AA0A5AF58F45Q34974330-B5B3D508-614E-4036-A259-E52458CA20C1Q35052356-D4897833-1E35-44D7-97A1-12C9B8ABD5E5Q35582808-6678A8BD-A432-46E9-95B4-DE1F09102000Q36524821-33495F07-DF4E-4FA0-A882-7DA45E8E374CQ38056526-84DDB02F-4BE7-44F6-83BC-59D76C08E6B5Q38185687-E4B2C73C-E6F2-42D1-9D0B-0D97979730D7Q38291763-F10292D8-3891-4251-9E97-F9FC93E12DD5Q41864184-E683EAC7-7B2E-4F53-9308-959B231A4EDFQ41934485-2EA4FD89-83F9-4C71-88AE-1E4EB8E2C3CFQ42265793-45838695-A2BD-4480-B4E6-785B66B5EFF3
P2860
A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A systematic review and meta-a ...... th inflammatory bowel disease.
@en
A systematic review and meta-a ...... th inflammatory bowel disease.
@nl
type
label
A systematic review and meta-a ...... th inflammatory bowel disease.
@en
A systematic review and meta-a ...... th inflammatory bowel disease.
@nl
prefLabel
A systematic review and meta-a ...... th inflammatory bowel disease.
@en
A systematic review and meta-a ...... th inflammatory bowel disease.
@nl
P2093
P2860
P921
P356
P1476
A systematic review and meta-a ...... th inflammatory bowel disease.
@en
P2093
Ali Rezaie
Shekoufeh Nikfar
Solmaz Ehteshami-Afshar
P2860
P304
P356
10.5114/AOMS.2011.26612
P577
2011-12-30T00:00:00Z